BACOZEN
Live / Applied — Statement of use — processing complete, to examiner (as of 10 Mar 2026)
What this means for you
Not registered yet, but its 15 Mar 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98450932
- Mark type
- Stylized text
- Filed
- 15 Mar 2024
- Published for opposition
- 04 Feb 2025
- Attorney of record
- Walter J. Tencza, Jr.
Goods and services
- Class 005 — Pharmaceuticals: Dietary and nutritional supplements containing herbal extract blend containing ashwagandha root extract, and bacopa extract from aerial part of bacopa plant
Owner
- NuAxon Bioscience, Inc., Princeton Junction, NJ, US
- NuAxon Bioscience, Inc., Princeton Junction, NJ, US
Prosecution history
- 10 Mar 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 22 Aug 2025 — USE AMENDMENT FILED
- 27 Feb 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 22 Aug 2025 — TEAS STATEMENT OF USE RECEIVED
- 01 Apr 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 04 Feb 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 04 Feb 2025 — PUBLISHED FOR OPPOSITION
- 29 Jan 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Jan 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 10 Jan 2025 — EXAMINER'S AMENDMENT ENTERED
- 10 Jan 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 10 Jan 2025 — EXAMINERS AMENDMENT E-MAILED
- 10 Jan 2025 — EXAMINERS AMENDMENT -WRITTEN
- 16 Oct 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 16 Oct 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE